3 hours Arrowhead, Sarepta Skyrocket After Duo Inks A Whopping $11.38 Billion DealInvestor's Business Daily
Shares of Arrowhead Pharmaceuticals catapulted Tuesday after the company inked a broad licensing deal with Sarepta Therapeutics.
The post Arrowhead, Sarepta Skyrocket After Duo Inks A Whopping $11.38 Billion Deal appeared first on Investor's Busin…